Learn More
Invitrogen™ CD263 (TRAIL-R3) Polyclonal Antibody
Description
Recommended positive controls: Human embryonic kidney cell line-293 or human T-cell line Jurkat. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | CD263 (TRAIL-R3) |
| Applications | ELISA, Flow Cytometry, Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.1% BSA and 0.1% sodium azide |
| Gene | TNFRSF10C |
| Gene Accession No. | O14798 |
| Gene Alias | Antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; Decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF receptor superfamily member 10c; TNF-related apoptosis-inducing ligand receptor 3; TNFRSF10C; TRAIL receptor 3; TRAIL receptor without an intracellular domain; TRAILR3; TRAIL-R3; TRID; Tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; UNQ321/PRO366 |
| Gene Symbols | TNFRSF10C |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.